Abstract: Aspects described herein relate to determining and/or scheduling resources for devices in view of cross-channel interference measured between the devices. In an aspect, a first user equipment (UE) can determine a signal measurement of a signal transmitted by a second UE in a first channel, determine, based at least in part on the signal measurement, a cross-channel interference parameter of interference experienced by the first UE, and transmit, to a serving base station that serves the first UE, an indication of the cross-channel interference parameter. In another aspect, a base station can determine a cross-channel interference parameter of interference experienced by a first UE in at least a first channel, based on a signal transmitted by a second UE in a second channel, and can schedule communications for the first UE based at least in part on the cross-channel interference parameter.

Abstract: An optical element driving mechanism includes a movable assembly, a fixed assembly, and a driving assembly. The movable assembly is configured to be connected to an optical element. The movable assembly is movable relative to the fixed assembly. The driving assembly is configured to drive the movable assembly to move relative to the fixed assembly in a range of motion. The optical element driving mechanism further includes a positioning assembly configured to position the movable assembly at a predetermined position relative to the fixed assembly when the driving assembly is not operating.

Abstract: A first communication device transmits first bitmap length capability information for the first communication device regarding block acknowledgment procedures, and receives second bitmap length capability information for a second communication device regarding block acknowledgment procedures. The first communication device performs a block acknowledgment procedure, including setting a block acknowledgment transmission window size for the block acknowledgment procedure based on the second bitmap length capability information for the second communication device, and a determination of whether a block acknowledgement frame used in the block acknowledgment procedure is a compressed block acknowledgement (C-BA) frame or a multi-station (multi-STA) block acknowledgement frame.

Abstract: Example implementations include a method, apparatus and computer-readable medium of wireless communication over a sidelink between a first user equipment (UE) and a second UE. The first UE may receive, from a base station, a sidelink resource configuration indicating physical sidelink control channel (PSCCH)/physical sidelink shared channel (PSSCH) occasions on which to monitor a PSCCH for a grant from a second UE. The first UE may determine an active time for monitoring the PSCCH based on a discontinuous reception (DRX) mode for a link with the base station, the DRX mode including an active state in which a physical downlink control channel (PDCCH) is monitored and an inactive state in which the PDCCH is not monitored. The first UE may monitor the PSCCH during one or more of the PSCCH/PSSCH occasions that coincide with the active time.

Abstract: The present invention relates to a non-fullerene acceptor compound containing benzoselenadiazole, and organic optoelectronic devices comprising the same.

Abstract: The present invention relates to a method for treating or alleviating an osteoporosis in a subject. The method comprises steps of identifying the subject having the osteoporosis, and administering to the subject an effective amount of a composition that increases a level of Discoidin Domain Receptor 1 (DDR1) protein in the subject.

Abstract: A cranial detoxifier device (CDD) that includes a free electron generator module, an infrared (IR) generator module, a heater module, a visible light generator, and a microcontroller that controls the free electron generator module, the infrared generator module, the heater module, and the visible light generator, the microcontroller and components of the free electron generator module, the IR generator module, the heater module, and the visible light generator residing in the housing of the CDD.

Abstract: An energizer that includes a plurality of energy producing modules each configured to emit a respective energy output of a type different from energy outputs of other modules, and an energy field integrator arranged to receive the energy outputs of the energy producing modules, to integrate the received energy outputs, and to output an integrated output, the energy field integrator comprising a plurality of gemstones arranged in an ordered array.

Abstract: An interconnect structure including a dielectric structure, plugs, and conductive lines is provided. The dielectric structure is disposed on a substrate. The plugs are disposed in the dielectric structure. The conductive lines are disposed in the dielectric structure and are electrically connected to the plugs. The sidewall of at least one of the conductive lines is in direct contact with the dielectric structure.

Abstract: A method for treating low bone mineral density associated with osteopenia, osteoporosis, and other diseases is disclosed. The method comprises administrating a composition comprising a 3,5-dihydroxypentanoic acid derivative according to Formula I to a mammal. A compound of 3,5-dihydroxypentanoic acid derivative having a structure according to Formula I or Formula II is also disclosed.

Abstract: Methods, systems, and devices for wireless communications are described. A user equipment (UE) may transmit, to a base station, a UE capability to receive a first portion of a tracking reference signal (TRS) and a second portion of the TRS, the first portion and the second portion associated with a TRS pattern. The UE may receive, from the base station, an indication of the TRS pattern, where the TRS pattern includes the first portion of the TRS pattern and the second portion of the TRS pattern. The UE may receive one or more TRSs according to the first portion of the TRS pattern and the second portion of the TRS pattern.

Abstract: A method for treating low bone mineral density associated with osteopenia, osteoporosis, and other diseases is disclosed. The method comprises administrating a composition comprising a 3,5-dihydroxypentanoic acid derivative according to Formula I to a mammal. A compound of 3,5-dihydroxypentanoic acid derivative having a structure according to Formula I or Formula II is also disclosed.

Abstract: A method for applying eyelash extensions includes: transporting an eyelash extension bundle to an eyelash extensions applying auxiliary, the eyelash extensions each having an attaching end, a root and a distal end, the eyelash extensions applying auxiliary having an attaching reference point, a first reference line and a second reference line, the first and second reference lines or imaginary extension lines thereof being joined at the attaching reference point; the attaching ends of the eyelash extensions being located right at the attaching reference point after the transportation; aligning two of the eyelash extensions in the eyelash extension bundle with the first and second reference lines, respectively, with a pair of tweezers; coating the attaching ends of the eyelash extensions with adhesive, and adhering the attaching ends coated with the adhesive to a root of a human eyelash. Thereby, eyelash extension bundles can all have uniform open angles with enhanced applying quality.

Abstract: A telescopic container comprises an upper part of the container, a lower part of the container and a top cover, the upper part of the container is sleeved on a periphery of the lower part of the container, and the lower part of the container can move in the upper part of the container; and the top cover is detachably connected to a top end of the upper part of the container and is provided with an air valve. A telescoping property between the lower part of the container and the upper part of the container is used in the invention, a user downwardly presses the upper part of the container, or upwardly presses the lower part of the container, or performs the two actions at the same time, so as to achieve an object of changing a capacity of the container.

Abstract: The present invention provides a method of additive manufacturing a 3D-printed article, comprising: (a) printing and depositing one or more layers of a slurry by using a 3D printer, wherein the slurry comprises a ceramic powder composition; (b) further injecting an oil around the one or more layers of slurry, wherein the height of the injected oil is lower than the height of the slurry; (c) repeating steps (a) and (b) until a main body with desired geometric shape is obtained; and (d) sintering the main body by heating to obtain the 3D-printed article wherein the temperature of a printing carrier of the 3D printer is from 30 to 80° C.

Abstract: The present invention relates to a non-fullerene acceptor compound containing benzoselenadiazole, and organic optoelectronic devices comprising the same.

Abstract: The present invention relates to a method for treating or alleviating an osteoporosis in a subject. The method comprises steps of identifying the subject having the osteoporosis, and administering to the subject an effective amount of a composition that increases a level of Discoidin Domain Receptor 1 (DDR1) protein in the subject.

Abstract: A method for applying eyelash extensions includes: transporting an eyelash extension bundle to an eyelash extensions applying auxiliary, the eyelash extensions each having an attaching end, a root and a distal end, the eyelash extensions applying auxiliary having an attaching reference point, a first reference line and a second reference line, the first and second reference lines or imaginary extension lines thereof being joined at the attaching reference point; the attaching ends of the eyelash extensions being located right at the attaching reference point after the transportation; aligning two of the eyelash extensions in the eyelash extension bundle with the first and second reference lines, respectively, with a pair of tweezers; coating the attaching ends of the eyelash extensions with adhesive, and adhering the attaching ends coated with the adhesive to a root of a human eyelash. Thereby, eyelash extension bundles can all have uniform open angles with enhanced applying quality.

Abstract: The present invention relates to a use of Discoidin Domain Receptor 1 (DDR1) inhibitor in preparing a medicament for preventing or treating a joint disease. The present invention further relates to a use of DDR1 activator in preparing a medicament for preventing or treating abnormalities of endochondral ossification-related conditions.

Abstract: Methods and systems for configuring a programmable logic device include receiving configuration data at an input of a first sector of the programmable logic device and dynamically routing the configuration data through the first sector to a second sector of the programmable device by selecting a first routing path out of the first sector or a second routing path out of the first sector.